| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 11/11/2009 | EP1372634B1 Use of fumaric acid amides |
| 11/11/2009 | EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 11/11/2009 | EP1313734B1 Aza heterocyclic derivatives and their therapeutic use |
| 11/11/2009 | EP1312369B1 Cardiac arrest fluid |
| 11/11/2009 | EP1278874B1 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 11/11/2009 | EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils |
| 11/11/2009 | EP1242118B1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 11/11/2009 | EP1181048B1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| 11/11/2009 | CN101578272A 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 11/11/2009 | CN101578271A 4-imidazolines as TAAR's ligands |
| 11/11/2009 | CN101578266A Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
| 11/11/2009 | CN101575367A Chinese yam glycosidoprotein and preparation method thereof |
| 11/11/2009 | CN101575335A Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof |
| 11/11/2009 | CN101575313A Production technique for synthesizing Manidipine Hydrochloride through separation with non-column chromatography |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574514A Product for treating myocardial infarction based on chitosan aquagel and growth factor |
| 11/11/2009 | CN101574510A Compound szechuan lovage rhizome and safflower soup used for treating thromboangitis obliterans |
| 11/11/2009 | CN101574472A Medicament for treating hyperpiesis and preventing complications |
| 11/11/2009 | CN101574456A Blood circulation and channel invigorating soup |
| 11/11/2009 | CN101574454A Restoration traditional Chinese medicine |
| 11/11/2009 | CN101574453A Traditional Chinese medicine for treating hemorrhoids |
| 11/11/2009 | CN101574450A Drug for treating heart disease and preparation method thereof |
| 11/11/2009 | CN101574447A Anti-fat lipid-lowering and blood-pressure-lowing hawthorn wine and preparation method thereof |
| 11/11/2009 | CN101574418A Traditional Chinese medicine tea for treating high blood pressure, hyperlipoidemia and hyperglycosemia |
| 11/11/2009 | CN101574411A Shuang dan orally disintegrating tablet |
| 11/11/2009 | CN101574410A Effective components of peony leaves as well as preparation method and application thereof |
| 11/11/2009 | CN101574395A Method for producing schisandra extract by adopting high voltage pulse electric field technology |
| 11/11/2009 | CN101574393A Method for preparing salvia miltiorrhiza colloid injection or infusion |
| 11/11/2009 | CN101574392A Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid |
| 11/11/2009 | CN101574391A Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside |
| 11/11/2009 | CN101574383A Prevention and treatment of diseases induced by microcirculation disturbance with panax notoginoside |
| 11/11/2009 | CN101574380A Flavone acetylsalicylate solid dispersion and preparation method thereof |
| 11/11/2009 | CN101574379A Flavone hippophaes self-emulsifying formulation and preparation method thereof |
| 11/11/2009 | CN101574361A Medical prescription and preparation method of catalpol-puerarin freeze-dried powder injection |
| 11/11/2009 | CN101574360A Application of epimedin in preparing medicines for treating diseases where estrogen needs supplementing |
| 11/11/2009 | CN101574359A Pharmaceutical composition for treating cardiovascular and cerebrovascular disease |
| 11/11/2009 | CN101574358A Application of ginsenoside Rb1 in prevention and treatment of diseases induced by microcirculation disturbance |
| 11/11/2009 | CN101574357A Prevention and treatment of diseases induced by microcirculation disturbance with panax notoginseng saponins R1 |
| 11/11/2009 | CN101574339A Application of beta-anhydroicaritin in preparation of medicine capable of preventing and treating cardiovascular and cerebrovascular diseases |
| 11/11/2009 | CN101574337A Prevention and treatment of microcirculation disturbance induced by endotoxin with compatible combination of salvianolic acid B and hydroxyethyl starch |
| 11/11/2009 | CN101574324A Felodipine sustained-release tablet and method for controlling sustained-release of Felodipine sustained-release tablet |
| 11/11/2009 | CN101574322A Bevantolol hydrochloride orally disintegrating tablet |
| 11/11/2009 | CN101574317A Nimodipine venous preparation and preparation method thereof |
| 11/11/2009 | CN101574144A Application of 3'-deoxyadenosine in reducing weight, enhancing insulin sensitivity and improving lipid metabolism |
| 11/11/2009 | CN100558899C Growth hormone fusion protein |
| 11/11/2009 | CN100558893C Modulation of eIF4E expression |
| 11/11/2009 | CN100558744C Use of a recombinant erythropoietin having high activity and reduced side effects |
| 11/11/2009 | CN100558742C Peptide gap junction modulators |
| 11/11/2009 | CN100558728C Calcitonin gene related peptide receptor antagonists |
| 11/11/2009 | CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
| 11/11/2009 | CN100558717C Novel medicine |
| 11/11/2009 | CN100558712C Therapeutic molecules and methods-1 |
| 11/11/2009 | CN100558411C Tenascin-C nucleic acid ligands |
| 11/11/2009 | CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 11/11/2009 | CN100558398C Modified naturetic compounds, conjugates, and uses thereof |
| 11/11/2009 | CN100558387C Traditional Chinese medicine capsule for treating cardiac failure |
| 11/11/2009 | CN100558386C Ginseng glucose injection and its quality control |
| 11/11/2009 | CN100558378C Chinese medicine for treating hypertension |
| 11/11/2009 | CN100558371C Application of Chinese medicine composition in treating cardiac and cerebral vascular diseases |
| 11/11/2009 | CN100558368C Method and material for treating immune diseases |
| 11/11/2009 | CN100558347C Ginseng-astragalus dispersion tablet formulation, and its preparing process |
| 11/10/2009 | US7615576 Prevention of neutrophil recruitment |
| 11/10/2009 | US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure |
| 11/10/2009 | US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation |
| 11/10/2009 | US7615548 Method to inhibit ischemia and reperfusion injury |
| 11/10/2009 | US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever |
| 11/10/2009 | US7615383 Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies |
| 11/10/2009 | CA2481482C Tropane derivatives as ccr5 modulators |
| 11/10/2009 | CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders |
| 11/10/2009 | CA2444145C Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illness and its complications |
| 11/10/2009 | CA2416785C Novel arylethene-sulfonamides |
| 11/10/2009 | CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 11/10/2009 | CA2378792C Aminothiazole derivatives and their use as crf receptor ligands |
| 11/10/2009 | CA2371213C Inhibitors of carboxypeptidase u |
| 11/05/2009 | WO2009134805A2 Antibodies to granulocyte-macrophage colony-stimulating factor |
| 11/05/2009 | WO2009134750A1 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 11/05/2009 | WO2009134741A1 Dual-acting antihypertensive agents |
| 11/05/2009 | WO2009134389A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 11/05/2009 | WO2009134383A2 Vinyl substituted fatty acids |
| 11/05/2009 | WO2009134203A1 New peptidomimetic compounds |
| 11/05/2009 | WO2009134147A1 Lipid compositions containing derivatives of epa and dha an their use thereof |
| 11/05/2009 | WO2009133970A1 Crystalline compound |
| 11/05/2009 | WO2009133834A1 Keto-amide derivative having inhibitory activity on endothelial lipase |
| 11/05/2009 | WO2009133831A1 Phenylpropionic acid derivative and use thereof |
| 11/05/2009 | WO2009133692A1 Quinoline compound |
| 11/05/2009 | WO2009133647A1 Polymerized cyclic nitroxide radical compound, and use thereof |
| 11/05/2009 | WO2009133470A2 Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration |
| 11/05/2009 | WO2009133458A1 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 11/05/2009 | WO2009133310A2 Combination of dronedarone with at least one diuretic, and therapeutic use thereof |
| 11/05/2009 | WO2009133269A1 Novel diomestine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 11/05/2009 | WO2009133180A1 Nicardipine hydrochloride dihydrate and chloroformate |
| 11/05/2009 | WO2009133136A1 Compounds |
| 11/05/2009 | WO2009132979A1 4-trimethylammonio-butyrates as cpt2 inhibitors |
| 11/05/2009 | WO2009132978A1 4-dimethylaminobutyric acid derivatives |
| 11/05/2009 | WO2009132510A1 Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks |
| 11/05/2009 | WO2009132457A1 Fgf-9 and its use relating to blood vessels |
| 11/05/2009 | WO2009132397A1 Methods and agents for modulating the level and/or activity of hif-2 alpha protein |
| 11/05/2009 | WO2009112954A3 Processes for the preparation of bosentan and related compounds |
| 11/05/2009 | WO2009091898A3 6-and 7-amino isoquinoline compounds and methods for making and using the same |
| 11/05/2009 | WO2009062914A3 Blood pressure lowering combination comprising ipp and/or vpp |